The effect of total plasma exchange on fulminant hepatic failure

Journal of Clinical Apheresis

Volumn 21, Issue 2, 2006, Pages 96-99

  Akdogan, M ^a   Camci, C ^a   Gurakar, A ^a   Gilcher, R ^b   Alamian, S ^a   Wright, H ^a   Nour, B ^a   Sebastian, A ^a  

^a INTEGRIS Nazih Zuhdi Transplant Institute   (United States)

^b Oklahoma Blood Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CHILD; FEMALE; HUMAN; HYPERAMMONEMIA; HYPERBILIRUBINEMIA; LIVER FAILURE; LIVER FUNCTION TEST; MALE; MIDDLE AGED; PLASMAPHERESIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CHILD; FEMALE; HUMANS; HYPERAMMONEMIA; HYPERBILIRUBINEMIA; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PLASMA EXCHANGE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33750113301     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20064     Document Type: Article

References (15)

1. Camci C, Akdogan M, Gurakar A, Gilcher R, Rose J, Monlux R, Alamain S, Wright H, Sebastian A, Nour B. The impact of total plasma exchange on early allograft dysfunction. Transplant Proc 2004;36:2567-2569.
2. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant Hepatic Failure: Summary of a workshop. Hepatology 1995;21:240-252
3. Mas A, Rodes J. Fulminant hepatic failure. Lancet 1997;349:1081-1085.
4. Winters JL, Pineda AA, McLeod BC, Grima KM. Therapeutic apheresis in renal and metabolic diseases. J Clin Apheresis 2000;15:53-73.
5. Sass DA, Shakil AO. Fulminant hepatic failure. Gastroenterol Clin N Am 2003;32:1195-1211
6. OPTN data as June 29, 2004. www.unos.org/latestdata/lpt-strat.asp
7. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-275.
8. Aladag M, Gurakar A, Jalil S, Wright H, Alamian S, Rashwan S, Sebastian A, Nour B. A liver transplant center experience with liver dialysis in the management of patients with fulminant hepatic failure: A preliminary report. Transplant Proc 2004; 36:203-205.
9. Weissenborn K. Clinical features of Hepatic Encephalopathy. In: Zakim D, Boyer TD, editors. Hepatology: a textbook of liver disease 4th ed., vol 1. Philadelphia: WB Saunders; 2003, p 431-444.
10. Larsen FS, Ejlersen E, Hansen BA, Mogensen T, Tygstrup N, Secher NH. Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: relationship with oxygen consumption. Eur J Gastroenterol Hepatol 1995;7:887-892.
11. Akamatsu K, Tada K. Plasma exchange therapy in patients with fulminant hepatic failure and limitations of effectiveness. Prog Clin Biol Res 1990;337:239-241.
12. Singer AL, Olthoff KM, Kim H, Rand E, Zamir G, Shaked A. Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg 2001;234:418-424.
13. Clemassen JO, Kondrup J, Nielsen LB, Larson FS, Ott P. Effects of high-volume plasmapheresis on ammonia, urea and amino acids in patients with acute liver failure. Am J Gas-troenterol 2001;96:1217-1223.
14. Shin K, Nagai Y, Hirano C, Kataoka N, Ono I, Yamamura E, Moriyama C, Horigome Y, Ehara T, Kamoda T, Suma-zaki R, Hanada T, Hamano K, Ogata T, Takita H. Survival rate in children with fulminant hepatitis improved by a combination of twice daily plasmapheresis and intensive conservative therapy. J Pediatr Gastroenterol Nutr 1989;9:163-166.
15. Biancofiore G, Bindi LM, Urbani L, Catalano G, Mazzoni A, Scatena F, Mosca F, Filipponi F. Combined twice-daily plasma exchange and continuous veno-venous hemodiafiltra-tion for bridging severe acute liver failure. Transplant Proc 2003;35:3011-3014.